0001803901false00018039012024-02-222024-02-220001803901us-gaap:CommonStockMember2024-02-222024-02-220001803901talk:WarrantsToPurchaseCommonStockMember2024-02-222024-02-22

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 22, 2024

Talkspace, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-39314		84-4636604
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

622 Third Avenue, New York, New York		10017
(Address of principal executive offices)		(Zip Code)

(212) 284-7206

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.0001 par value per share		TALK		Nasdaq Global Select Market
Warrants to purchase common stock		TALKW		Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

---

Item 2.02. Results of Operations and Financial Condition.

Talkspace, Inc. (the “Company”) issued a press release on February 22, 2024 announcing its financial results for the quarter and year ended December 31, 2023. A copy of the press release issued in connection with this announcement is furnished as Exhibit 99.1 attached hereto.

 

The information in this Item 2.02, including the information contained in Exhibit 99.1 of this Current Report on Form 8-K, is being furnished hereby and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure.

On February 22, 2024, the Company posted supplementary slides (the “Slides”) regarding the Company’s financial results for the quarter and year ended December 31, 2023 on the Company’s investor relations website at https://investors.talkspace.com/investor-relations. The Slides are furnished as Exhibit 99.2. The Company may use the Slides, in whole or in part, and possibly with minor modifications, in connection with presentations to investors after such date.

 

The information contained in the Slides is summary information that is intended to be considered in the context of the Company’s Securities and Exchange Commission (“SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures.

 

This information in this Item 7.01, including the information contained in Exhibit 99.2 of this Current Report on Form 8-K, is being furnished hereby and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits
 

Exhibit Number		Description
99.1		Press Release issued by Talkspace, Inc. dated February 22, 2024.
99.2		Supplementary Slides: Talkspace, Inc. 2023 Fourth Quarter Earnings Presentation - February 22, 2024.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

---

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Talkspace, Inc.
Date:	February 22, 2024	By:	/s/ Jennifer Fulk
			Jennifer Fulk Chief Financial Officer

 

---

Exhibit 99.1

 

 

Talkspace Announces Fourth Quarter and Full Year 2023 Results

4Q 2023 Payor revenue grew 138% year-over-year

4Q 2023 Operating expenses of $23.6 million, down 37% year-over-year

4Q 2023 Net loss of $1.3 million; Adjusted EBITDA1 loss of $0.3 million, an improvement of 97% year-over-year

Provides 2024 guidance with revenue $185-$195 million and adjusted EBITDA1 $4-$8 million

Announces Initial Share Repurchase Program of $15M

 

 

NEW YORK, New York - February 22, 2024 – Talkspace, Inc. (NASDAQ: TALK), today reported fourth quarter and full year 2023 financial results.

		Three Months				Full Year
Unaudited
Year Ended December 31, 2023		Results		Variance from Prior Year %		Results		Variance from Prior Year %
(In thousands unless otherwise noted)
Number of eligible lives at year end (in millions)		131		42%		131		42%
Number of completed Payor sessions		249.8		95%		850.6		99%
Number of Consumer active members at year end		11.7		(24)%		11.7		(24)%
Total revenue		$42,418		40%		$150,045		25%
Gross profit		$20,971		30%		$74,380		23%
Gross margin %		49.4%				49.6%
Operating expenses		$23,554		(37)%		$97,589		(32)%
Net loss		$(1,306)		93%		$(19,182)		76%
Adjusted EBITDA1		$(306)		97%		$(13,529)		77%
Cash and cash equivalents at year end		$123,908		—		$123,908		—

(1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most directly comparable GAAP measure, see “Reconciliation of Non-GAAP Results to GAAP Results.”

 

Dr. Jon Cohen, CEO of Talkspace, said, “2023 was a pivotal year for Talkspace, demonstrating our commitment to strategic execution. Our achievements and streamlined strategy have significantly fortified our foundation for 2024. We're poised for substantial growth in Payor revenue and continue to lead in covered mental healthcare. The opportunities in Direct to Enterprise (“DTE”) are vast, and with our scalable infrastructure, we are set for profitable expansion.”

Jennifer Fulk, CFO of Talkspace, said, “The strategic measures we've implemented throughout the past year have significantly strengthened our financial foundation and operational efficiency. Our disciplined approach to cost management and investment in scalable capabilities have not only enhanced our operating leverage but also positioned us well for sustained profitable growth.”

 

---

Fourth Quarter 2023 Key Performance Metrics

Full Year 2023 Key Performance Metrics

Financial Guidance

The following guidance is based on current market conditions and expectations and the information available to the Company today:

Share Repurchase Program

The Company’s Board of Directors has approved an initial share repurchase program authorizing the Company to repurchase up to fifteen million dollars ($15,000,000) of its outstanding shares of common stock over the next twenty-four months. The Company may repurchase the shares periodically through various methods in compliance with applicable state and federal securities laws. The timing of purchases, the target number of shares, and the pricing per purchase will be determined by Management at its discretion. Such repurchases will be funded from cash on hand. The repurchase program may be modified, suspended, or discontinued at any time at the Company’s discretion without prior notice.

 

 

---

Conference Call, Presentation Slides, and Webcast Details

The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call’s completion and remain available for approximately 90 days.

About Talkspace

Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace’s core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.

All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 130 million Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.

For more information, visit www.talkspace.com.

 

‍For Investors:

Neal Nagarajan

Sloane & Company

(301) 273-5662

nnagarajan@sloanepr.com

 

For Media:

John Kim

SKDK

(310) 997-5963

jkim@skdknick.com

 

 

 

---

Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 10, 2023, and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.

 

 

 

 

 

---

 

Talkspace, Inc.

Consolidated Statements of Operations

 

		Three Months Ended December 31,						Year Ended December 31,
		2023		2022		% Change		2023		2022		% Change
(in thousands, except percentages, share and per share data)		Unaudited						Unaudited
Revenue:
Payor revenue		$25,362		$10,665		137.8		$80,823		$36,168		123.5
DTE revenue		8,897		8,615		3.3		33,614		28,241		19.0
Consumer revenue		8,159		10,961		(25.6)		35,608		55,158		(35.4)
Total revenue		42,418		30,241		40.3		150,045		119,567		25.5
Cost of revenues		21,447		14,066		52.5		75,665		59,229		27.7
Gross profit		20,971		16,175		29.7		74,380		60,338		23.3
Operating expenses:
Research and development, net		3,867		4,866		(20.5)		17,571		21,659		(18.9)
Clinical operations, net		1,478		277		433.6		6,159		6,591		(6.6)
Sales and marketing		12,846		14,128		(9.1)		52,544		72,842		(27.9)
General and administrative		5,363		11,801		(54.6)		21,315		36,270		(41.2)
Impairment of goodwill		—		6,134		(100.0)		—		6,134		(100.0)
Total operating expenses		23,554		37,206		(36.7)		97,589		143,496		(32.0)
Operating loss		(2,583)		(21,031)		87.7		(23,209)		(83,158)		72.1
Financial (income), net		(1,330)		(2,851)		(53.3)		(4,245)		(3,740)		13.5
Loss before taxes on income		(1,253)		(18,180)		93.1		(18,964)		(79,418)		76.1
Taxes on income		53		127		(58.3)		218		254		(14.2)
Net loss		$(1,306)		$(18,307)		92.9		$(19,182)		$(79,672)		75.9
Net loss per share:
Basic and Diluted		$(0.01)		$(0.11)		90.9		$(0.12)		$(0.51)		76.5
Weighted average number of common shares:
Basic and Diluted		167,485,398		159,343,311				165,039,920		156,885,256

 

 

 

---

Talkspace, Inc.

Consolidated Balance Sheets

		December 31, 2023				December 31, 2022
(in thousands)		Unaudited
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		$	123,908			$	138,545
Accounts receivable			10,174				9,640
Other current assets			5,718				4,372
Total current assets			139,800				152,557
Property and equipment, net			314				677
Intangible assets, net			1,786				2,529
Other assets			321				491
Total assets		$	142,221			$	156,254
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable		$	6,111			$	6,461
Deferred revenues			3,069				4,355
Accrued expenses and other current liabilities			12,468				16,502
Total current liabilities			21,648				27,318
Warrant liabilities			1,842				939
Other liabilities			85				461
Total liabilities			23,575				28,718
STOCKHOLDERS’ EQUITY:
Common stock			16				16
Additional paid-in capital			389,014				378,722
Accumulated deficit			(270,384	)			(251,202	)
Total stockholders’ equity			118,646				127,536
Total liabilities and stockholders’ equity		$	142,221			$	156,254

 

 

 

---

 

Talkspace, Inc.

Consolidated Statements of Cash Flows

 

		Year Ended December 31,
		2023				2022
(in thousands)		Unaudited
Cash flows from operating activities:
Net loss		$	(19,182	)		$	(79,672	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			1,196				1,357
Stock-based compensation			8,395				12,116
Remeasurement of warrant liabilities			903				(3,131	)
Impairment of goodwill			—				6,134
Increase in accounts receivable			(534	)			(4,126	)
(Increase) decrease in other current assets			(1,346	)			5,080
Decrease in accounts payable			(350	)			(968	)
Decrease in deferred revenues			(1,286	)			(2,831	)
(Decrease) increase in accrued expenses and other current liabilities			(4,034	)			4,862
Other			(155	)			102
Net cash used in operating activities			(16,393	)			(61,077	)
Cash flows from investing activities:
Purchase of property and equipment			(151	)			(350	)
Proceeds from sale of property and equipment			10				33
Net cash used in investing activities			(141	)			(317	)
Cash flows from financing activities:
Proceeds from exercise of stock options			2,707				3,181
Payments for employee taxes withheld related to vested stock-based awards			(810	)			(853	)
Payments for reverse capitalization, net of transaction costs			—				(645	)
Net cash provided by financing activities			1,897				1,683
Net decrease in cash and cash equivalents			(14,637	)			(59,711	)
Cash and cash equivalents at the beginning of the year			138,545				198,256
Cash and cash equivalents at the end of the year		$	123,908			$	138,545

 

---

Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.

A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

 

 

---

Adjusted EBITDA

We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, (v) impairment of goodwill, and (vi) certain non-recurring expenses, where applicable.

 

Talkspace, Inc.

Reconciliation of Non-GAAP Results to GAAP Results

 

		Three Months Ended December 31,								Year Ended December 31,
		2023				2022				2023				2022
(in thousands)		Unaudited								Unaudited
Net loss		$	(1,306	)		$	(18,307	)		$	(19,182	)		$	(79,672	)
Add:
Depreciation and amortization			283				351				1,285				1,357
Financial (income), net (1)			(1,330	)			(2,851	)			(4,245	)			(3,740	)
Taxes on income			53				127				218				254
Stock-based compensation			1,994				2,730				8,395				12,116
Impairment of goodwill			—				6,134				—				6,134
Non-recurring expenses (2)			—				2,947				—				4,880
Adjusted EBITDA		$	(306	)		$	(8,869	)		$	(13,529	)		$	(58,671	)

 

(1) For the three months ended December 31, 2023, financial (income), net, primarily consisted of $1.6 million of interest income from our money market accounts partially offset by $0.3 million in losses resulting from the remeasurement of warrant liabilities. For the year ended December 31, 2023, financial (income), net, primarily consisted of $5.3 million of interest income from our money market accounts partially offset by $0.9 million in losses resulting from the remeasurement of warrant liabilities. For the three months ended December 31, 2022, financial (income), net, primarily consisted of $2.7 million in gains resulting from the remeasurement of warrant liabilities. For the year ended December 31, 2022, financial (income), net, primarily consisted of $3.1 million in gains resulting from the remeasurement of warrant liabilities.

(2) For the three months ended December 31, 2022, non-recurring expenses primarily consisted of a $5.5 million accrual for estimated litigation expenses, partially offset by one-time savings related to marketing expenses. For the year ended December 31, 2022, non-recurring expenses primarily consisted of a $5.5 million accrual for estimated litigation expenses.

---

Feeling better starts with a single message 2023 Fourth Quarter Earnings Presentation FEBRUARY 22,2024 Exhibit 99.2

---

This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this presentation, including but not limited to: our history of losses; the rapid evolution of our business and the markets in which we operate; our ability to continue growing at the rates we have historically grown, or at all; the development of the virtual behavioral health market; a deterioration in general economic conditions as a result of inflation, increased interest rates or otherwise; competition in our industry; and our relationships with affiliated professional entities to provide physician and other professional services. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in under the caption “Risk Factors” in our Annual Report on Form 10-K for the annual period ended December 31, 2022 filed with the Securities and Exchange Commission (“SEC”) on March 10, 2023 and in our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. We do not give any assurance that we will achieve our expectations. Certain information contained in this presentation relate to or are based on studies, publications, surveys and other data obtained from third-party sources and the Company’s own internal estimates and research. While the Company believes these third-party sources to be reliable as of the date of this presentation, it has not independently verified, and makes no representation as to the adequacy, fairness, accuracy or completeness of, any information obtained from third-party sources, and you are urged not to give undue weight to such third-party information. While the Company believes its internal research is reliable, such research has not been verified by any independent source. This presentation may contain the measure Adjusted EBITDA, Adjusted EBITDA margin, and non-GAAP costs and expenses (including non-GAAP cost of revenue, research and development, sales and marketing, and general and administrative) which are non-GAAP financial measure. For additional information about the measure and a reconciliation to the most closely comparable GAAP measure see the Talkspace Investors Relations website at investors.talkspace.com. Disclaimer 2

---

Revenue is presented on an as-reported basis. Includes sessions from Managed Behavioral Health (“MBH”) and Employee Assistance Programs (“EAP”). Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to the most directly comparable GAAP measure, see the appendix to this presentation. 3 Payor Sessions2 851 426 Revenue1 and % Composition $0 2022 2023 $28 24% $150 1,000 500 0 USD, millions Thousands 2022 2023 $34 22% ($13.5) ($58.7) 2022 2023 USD, millions ($60) ($40) $(20) $0 $120 $55 46% 2023 Performance Highlights Adjusted EBITDA3 Loss Consumer Payor $36 30% DTE $81 54% $100 $50 $150 $36 24%

---

Grew network by 75% to 5,300 with focus on clinical quality Continue to enhance therapist experience and satisfaction and improve access metrics 4 2023 Execution of Strategic Priorities Payor Revenue Growth 3. Providers’ Platform-of-Choice 4. Operational Excellence Reduced operating expenses more than 30% Revenue Cycle Management Operating above industry benchmarks Built scalable controls and operational processes Grew covered lives from 92M to 131M Expanded same-basis capture rate almost 50% 2. Direct-to-Enterprise Growth Rebuilt highly experienced sales team Launched two major teens contracts Grew value and quality of pipeline

---

Revenue and Gross Profit Revenue $0 $10 $20 $30 Q1‘23 Q2‘23 $35 $35.6 Q3‘23 5 53.5% $0 Gross Profit $10 $20 USD, millions 49.8% 50.2% $16.7 Q1‘23 Q2‘23 Q2‘23 $5 $15 % Margin 65% 60% 55% 50% 45% 40% 35% 50.0% $17.8 Q4‘23 $18.5 Consumer Payor DTE $9.1 $7.9 Gross Profit and % Margin $25 $15 $5 $9.5 $33.3 $14.8 $9.8 $18.5 48.8% $18.8 $8.0 $18.5 $38.6 $8.5 $8.0 $22.1 $40 Q4‘23 $45 $50 $42.4 $8.2 $8.9 $25.4 $8.7 49.4% $21.0 USD, millions

---

6 Operating Expense and Adjusted EBITDA1 $0 USD, millions $(6.4) Q1‘23 Q2‘23 Q3‘23 $(4.0) Q4‘23 Operating Expenses $0 USD, millions Q1‘23 SBC + Non-recurring Normalized OpEx Q2‘23 Q3‘23 $2.1 $22.1 Q4‘23 $23.5 $2.3 Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation to the most directly comparable GAAP measure, see the appendix to this presentation. Adjusted EBITDA Loss1 $25.8 $24.2 $(2.8) $2.0 $22.1 $24.0 $2.0 $21.6 $23.6 $10 $20 $25 $30 $5 $15 $(2) $(4) $(6) $(8) $(0.3) 51% 57% 62% 70% Normalized OpEx as % of Revenue

---

2024 Guidance and 3-Year Outlook1 Guidance and Outlook are based on current market conditions and expectations and what we know today. Adjusted EBITDA is a non-GAAP financial measure. We do not provide a forward-looking reconciliation of our guidance for adjusted EBITDA as the amount and significance of items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These special items could be meaningful. 7 USD +20 to +25% Preliminary 3-Year Outlook Revenue CAGR +12% to +15% Adjusted EBITDA2 Margin ~ $185M to $195M +23% to +30% Y/Y 2024 Guidance Revenue Adjusted EBITDA2 $4M to $8M +$18M to 22M Y/Y

---

Strong Long-Term Growth Plan ➡️Launch needle-moving strategic partnerships ➡️Continued momentumwith teens ➡️Grow Capture Rate ➡️Grow Covered Lives ➡️Pioneer investments in clinical A.I. tools ➡️Grow Revenue ➡️Grow Profitability 8

---

9 Appendix

---

Non-GAAP Financial Measures In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results. A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation Adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful. 10

---

11 Reconciliation of Net Loss to Adjusted EBITDA Adjusted EBITDA We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, (v) impairment of goodwill, and (vi) certain non-recurring expenses, where applicable. Talkspace, Inc. Reconciliation of Non-GAAP Results to GAAP Results